La Story cover image

Novo Nordisk, la pilule du coupe-faim Wegovy ne passe plus en Bourse

La Story

00:00

Plateau des ventes aux États‑Unis

Myriam analyse le ralentissement des initiations de traitements et son impact sur la croissance.

Play episode from 06:21
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app